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McGuire and Ruhm (1993) develop an interesting and policy-relevant model of 
workplace drug abuse policy. They examine workers’ choice to undergo treatment 
(rehabilitation) for substance abuse and firms’ choice of drug-testing policies, 
concluding that ‘labor market incentives will generally lead to too little treatment 
and too much testing’. 
Drug addicts are assumed to have a ‘high’ probability ( p> of causing a costly 
workplace accident while non-addicts are assumed to have a ‘low’ probability 
(a < p) of causing an accident. Another key assumption is that treatment is 
perfect. That is, any ‘addict’ undergoing treatment changes from a ‘high’ to a 
‘low’ risk with probability one. Although the authors acknowledge that actual 
treatment regimes are imperfect and discuss how imperfect treatment can be 
incorporated, they do not appear to recognize the ways in which their qualitative 
results depend on their simplifying assumption. Allowing partially effective treat- 
ment by assuming that the accident risk of treated drug users falls to (Y with some 
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probability p changes some of their conclusions and yields additional insights 
about the model. ’ 
Over two decades of research on the effectiveness of substance abuse treatment 
programs has uniformly found that relapse is common. One of the most compre- 
hensive and widely cited studies is the Treatment Outcome Prospective Study (see 
Hubbard et al., 1989). Using an index for multiple drug abuse, less than ten 
percent of treatment center clients were classified as ‘minimal’ drug abusers 
during the year prior to treatment. At a three to five year follow-up, approximately 
thirty percent were classified as minimal drug users. Using a simplistic definition 
of treatment success as achieving minimal drug use, this translates to a p on the 
order of 0.25. Defined more broadly, long-term indicators of success are not quite 
as bleak. There was also a shift from more severe patterns of abuse (e.g. cocaine 
or opioid dominated drug abuse) to less severe patterns (alcohol or marijuana 
dominated). Thus, some patients who failed to maintain minimal drug use patterns 
may still have achieved gains. Because multiple and shifting dependencies are 
ignored, treatment results are more impressive when stated in terms of any 
particular drug. For example, clients of residential facilities experienced 61 percent 
declines in the prevalence of ‘regular’ heroin use. Corresponding declines for 
regular cocaine, marijuana, and non-medical psychotherapeutic use were 64 
percent, 39 percent and 82 percent, respectively. Although the likelihood of 
regular drug abuse declined, it remained substantial for all classes of drugs. ’ 
The qualitative difference between perfect and imperfect rehabilitation in the 
McGuire and Ruhm model is easy to understand. With perfect rehabilitation, 
having undergone treatment certifies the worker as being low risk and renders the 
worker’s past drug abuse history irrelevant. When employers can observe treat- 
ment, treated addicts are able to send a favorable signal about their accident risk. 
In equilibrium, McGuire and Ruhm show that fewer addicts pursue rehabilitation 
than is socially optimal. However, due to the positive signal value of treatment, 
the extent of undertreatment is lower than it would be if treatment were unobserv- 
able. Drug users are more likely to obtain treatment when they can obtain the 
additional benefit of being able to certify their drug-free status. 
By way of contrast, observable but imperfect treatment conveys two useful 
pieces of information to employers. As in the perfect treatment case considered by 
’ This comment focuses on the same ‘interesting’ equilibrium that McGuire and Ruhm concentrate 
on. In this equilibrium, no non-addicts undergo rehabilitation and a fraction of addicts chooses 
treatment. 
’ Regular use is defined as daily or weekly USC of a substance. In residential programs, regular 
heroin use declined from 31% pre-treatment to 12% at three to five year follow-up. Likewise, regular 
cocaine use fell from 28% to 10%. regular non-medical use of psychotherapeutic drugs fell from 50% 
to 9%, and regular marijuana use fell from 64% to 39%. Note that abuse of psychotherapeutic drugs 
and marijuana were usually not the primary problem leading to admission. Clients of outpatient 
programs experienced similar declines in usage. 
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McGuire and Ruhm, treatment signals a reduction in the expected cost of accidents 
relative to untreated addicts. However, undergoing treatment also signals the 
worker’s history of drug abuse. Because of the possibility of treatment failure 
(relapse), this information is no longer benign. In particular, the probability of an 
accident could easily be greater among treated users than in the general untreated 
population. In this scenario, a wage policy paying each worker his or her expected 
marginal product penalizes workers for seeking treatment. 3 The observability of 
treatment becomes a disincentive to seek help and increases the extent of 
undertreatment relative to the unobservable treatment case. 4 
The following proposition formalizes these notions. Again, consider McGuire 
and Ruhm’s ‘interesting’ equilibrium in which non-drug abusers do not seek 
treatment while some fraction, 3/p, of abusers undergo treatment. First, define: 
A = share of P-risk workers (drug abusers) initially in the population; A, = share 
of P-risk workers after the fraction rP of ps get unobserved treatment with a 
success rate of p; A, = share of P-risk workers among those treated. 
Proposition: For any fraction of drug abusers in the general population, A, 
there exists a probability of treatment success, p*, such that treated drug abusers 
are better off when employers can observe the treatment decision if the success 
rate exceeds p*. Further when A is small, p* declines in the initial fraction of 
drug abusers in the population. 
Proof: When no non-abusers seek treatment, the fraction of high risk workers 
in the population after the fraction pg(p) are treated successfully is A, = h[l - 
pyP(p)]. This is the firm’s objective assessment of the probability that a worker 
presents a high risk of accident when treatment is unobservable. The prevalence of 
high risks among treated workers is simply the failure rate when only ps seek 
treatment (A, = 1 -p). This is the firm’s objective assessment of the probability 
that a treated worker is a high risk when treatment is observable. 
In the McGuire and Ruhm model, wage equals expected, net of accident costs 
marginal product and is strictly decreasing in the firm’s belief about the worker’s 
’ With existing success rates, it is difficult to imagine a job candidate announcing to a prospective 
employer that he or she has just completed a drug rehabilitation program. The primary exception occurs 
when the employer already has knowledge of the drug use history, but this is not the case analyzed by 
McGuire and Ruhm. 
4 In a different context, Burtless (1985) found that targeted wage subsidies actually harmed their 
intended beneficiaries. A group of AFDC and general assistance recipients were given training in job 
search skills and then randomly assigned either to search on their own or to receive vouchers that 
would reimburse employers for half of the worker’s first year wages and one quarter of the second year 
wages. Despite the substantial subsidy, the voucher group was significantly less likely to secure 
employment. Burtless concludes that by signaling status as a welfare recipient, the vouchers stigma- 
tized workers. 
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likelihood of causing an accident. Thus, treated abusers are better off under 
whichever observability regime firms hold the most optimistic beliefs about their 
accident probability. That is, workers prefer observable treatment when: 
A[1 -PYpyB(P)] > l -p (1) 
and unobservable treatment when the opposite inequality holds. A success proba- 
bility p* that equates these expressions leaves workers indifferent between 
observable and unobservable treatment. p* is implicitly defined by: 
A[1 -P*Yp(P*)] = 1 -P* (2) 
It is easy to see that (2) can only hold as an equality for p* strictly between 0 
and 1. As shown by McGuire and Ruhm, it is never privately optimal for all drug 
abusers to obtain therapy. That is, ~~(p* ) < 1. Thus, when p = 1, (1) becomes: 
A[ 1 - Y#)] > 0 
With perfect rehabilitation, treated workers strictly prefer observability because 
firms hold more favorable beliefs when they can observe treatment. This is the 
positive signal value of treatment discussed by McGuire and Ruhm. Conversely, 
when p = 0, the inequality in (1) changes direction, becoming A < 1. For very 
unsuccessful treatments, workers prefer unobservability. The firm’s estimate of the 
probability that a treated worker presents a high accident risk is greater when 
treatment is observed (in fact, the firm knows that such a worker is high risk 
because treatment is useless). Combining these facts, it is clear that (2) can only 
hold for p* strictly between 0 and 1. ’ 
Rearranging (2) defines an identity F( p*, A) = 0 which can be implicitly 
differentiated for: 
aP* P”Y&P”) - 1 -= 
ah 





The numerator is unambiguously negative and the denominator is certain to be 
positive for small enough fractions of addicts in the general population (A). When 
the prevalence of drug abuse is low (the case considered by McGuire and Ruhm), 
p* unambiguously declines in A. The lower the prevalence of drug addicts, the 
5 For the purposes of this exposition, it is assumed that p* IS unique and y@(p) is continuous. The 
arguments made hem continue to hold when multiple values of p* satisfy (2) with the following 
modification. Treated workers are better off under observability for any p > p*’ where p*’ is the 
largest value of p* satisfying (2). Likewise, workers will prefer unobservability at any p < p*” where 
P *” is the lowest value of p* satisfying (2). At any p such that p*” < p < p*‘, treated workers arc 
better off under whichever regime firms hold the most optimistic beliefs about their accident 
probability. A similar extension of the argument covers the case in which -ys( p) is discontinuous. 
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more successful rehabilitation must be for treated workers not to prefer hiding 
their treatment status in order to pool with non-addicts. 
McGuire and Ruhm treat the observabililty of treatment as exogenous. How- 
ever, the partially effective treatment scenario can endogenize the observability 
regime. It seems plausible to hypothesize that workers can credibly demonstrate 
that they have completed treatment. For example, they might show the employer 
letters from physicians or representatives of accredited treatment facilities, bills, 
canceled checks or insurance explanation-of-benefits forms. Given the confiden- 
tiality of the provider/patient relationship, it is also plausible to hypothesize that 
workers can hide their treatment history from employers if they choose to keep 
this information private. ’ 
On the basis of the probability of relapse and the prevalence of treated and 
untreated addicts in the population, treated workers can decide whether or not 
revealing their treatment status is advantageous. When treatment is highly success- 
ful, the observable treatment regime is the equilibrium outcome as the positive 
signal value of therapy outweighs the negative effect of revealing drug abuse 
history. Alternatively, if the failure rate is substantial, the cost of revealing past 
drug abuse exceeds the worker’s benefit from the positive treatment signal and the 
unobservable treatment regime pertains. ’ If the prevalence of drug abusers in the 
population is very low, rehabilitation must be nearly perfect before treatment 
provides a favorable signal. In a population initially containing many drug abusers, 
even poor treatment offers workers some opportunity to distinguish themselves 
from the chemically dependent masses. Under realistic drug abuse prevalence and 
treatment success rates, it seems very unlikely that treated workers would benefit 
from revealing their status. 
The observation that gaining employees’ trust has been a major obstacle in 
establishing employee assistance plans (EAPs) for drug abusers can only be 
explained in an imperfect treatment environment. Workers often hesitate to take 
part in firm-based substance abuse programs because they are revealing informa- 
tion that the employer may use against them. Even if workers somehow develop 
enough trust to come forward, McGuire and Ruhm’s observable treatment model 
may not be relevant. With high relapse rates, firms can only establish trust by 
refraining from making downward wage revisions when workers voluntarily reveal 
their treatment status. A more complicated model with repeated interactions 
’ Because of these same confidentiality requirements, untreated workers cannot credibly communi- 
cate that they have not undergone treatment. 
’ Some workers may have above or below average probabilities of success. Workers who believe 
their success probability exceeds p* may reveal their treatment status in an attempt to communicate 
their optimistic prognosis. However, this scenario seems unlikely. Workers with lower likelihoods of 
success may wish to pool with the self-revealed treated addicts. More importantly, empirical evidence 
indicates that it is very difficult to predict which individuals will relapse. For example, McLellan et al. 
(1993) find that only a small proportion of the variance of the six month success in reducing drug 
abuse can be explained by an impressive set of independent variables. 
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between workers and firms would be required to give firms an incentive to nurture 
a reputation for trustworthiness. If trust can be established, EAPs may decrease the 
extent of undertreatment by lowering the effective cost to the employee as workers 
face lower travel and search costs as well as lower out-of-pocket costs if firms 
subsidize the program. 
Explicitly considering the imperfect treatment case not only adds realism to the 
model, but it also clarifies an interesting ‘second best’ result. In McGuire and 
Ruhm’s original formulation, treatment confidentiality (unobservability) reduces 
welfare. A policy requiring disclosure of treatment records to firms would make 
workers better off. Further, workers would be more likely to seek treatment under 
mandated disclosure. 
Imperfect treatment can yield the opposite conclusion. Confidentiality prevents 
wage policies from discouraging workers from obtaining efficient treatment by 
allowing treated high risk workers to pool with low risk workers whenever it is 
beneficial not to reveal drug abuse status. If treatment is observable (e.g. if 
disclosure is mandated), drug abusers can mimic low risk workers only if they 
remain untreated. Due to moral hazard, the extent of undertreatment relative to the 
social optimum worsens. This conclusion is diametrically opposed to McGuire and 
Ruhm’s finding for the perfect treatment case. Private information can actually be 
welfare-enhancing and a policy requiring disclosure would be detrimental. Pro- 
vided workers can credibly communicate that they have received therapy, it 
becomes clear that treatment confidentiality is an optimum policy. If treatment is 
so successful that treatment provides a favorable signal about accident risk, treated 
workers will voluntarily disclose their status to firms. Presumably, insurance 
records and authorizations for release of medical records would ensure the 
credibility of these claims. Alternatively, if treated drug abusers have substantial 
relapse rates, the ability to hide the fact of treatment from employers prevents 
wage and hiring policies from discouraging drug abusers from seeking help. Under 
current success rates, it is difficult to imagine that many workers would voluntarily 
disclose that they have undergone substance abuse therapy. The only notable 
exceptions would seem to those whose drug abuse history has already been 
discovered. Because their employers already hold negative beliefs about their 
accident rates, even imperfect treatment improves the firm’s prior beliefs. 
References 
Burtless. G., 1985, Arc targeted wage subsidies harmful? Evidence from a wage voucher experiment, 
Industrial and Labor Relations Review 3Y. 105-l 11. 
Hubbard, R.L. et al., 1989, Drug abuse treatment: A national study of cffectivcncss (University of 
North Carolina Press, Chapel Hill, NC). 
McGuire, T.G. and C.J. Ruhm, 1993, Workplace drug abuse policy, Journal of Health Economics 12, 
1 Y-38. 
McLellan, A.T. et al., 1993, Similarity of outcome predictors across opiate, cocaine and alcohol 
treatments: role of treatment services. Journal of Consulting and Clinical Psychology, forthcoming. 
